MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
October 12, 2011
Matt Koppenheffer
3 Home Run Stocks My Wife Found My wife knocked three stock picks out of the park. What's the secret of her success? mark for My Articles similar articles
The Motley Fool
April 19, 2005
Stephen D. Simpson
Pfizer Fosters Fertile Future Results in the "here and now" aren't bad, but it will take a couple of years to build growth. Of course, investors must do their own research and make their own decisions. mark for My Articles similar articles
The Motley Fool
January 9, 2012
Matt Koppenheffer
What's in Store for McDonald's in 2012? The past year was a great one for both McDonald's and its investors. Can 2012 be a repeat? mark for My Articles similar articles
The Motley Fool
November 7, 2011
Dan Caplinger
Has Pfizer Become the Perfect Stock? The pharma giant still faces the challenge of patent expirations that could outpace its pipeline development. mark for My Articles similar articles
The Motley Fool
January 6, 2012
Matt Koppenheffer
A Golden Year for McDonald's McDonald's shareholders celebrate the Golden Arches after a year of crushing the rest of the market. mark for My Articles similar articles
The Motley Fool
February 22, 2007
Ryan Fuhrmann
Dueling Fools: Pfizer Bull The drug giant has ample firepower. The current company valuation largely ignores Pfizer's upside potential past 2008. mark for My Articles similar articles
The Motley Fool
November 17, 2011
A Brief History of Chevron's Returns The reason Chevron was such a boon to shareholders is explained here. mark for My Articles similar articles
The Motley Fool
January 10, 2012
Dan Caplinger
2012 Could Be Even Better for Chevron Let's look at this year's prospects for this company. mark for My Articles similar articles
The Motley Fool
December 22, 2010
Dayana Yochim
7 Stocks to Pretty-Up Your Portfolio 'Tis the season to primp and preen and these are the companies that help consumers -- and investors -- look their best. mark for My Articles similar articles
The Motley Fool
April 20, 2007
Ryan Fuhrmann
Discerning Pfizer's Pfuture The company is undergoing a transformation, but that doesn't mean it isn't worth a look from investors. mark for My Articles similar articles
The Motley Fool
November 14, 2007
John Rosevear
Storming the Virtual Mall Surviving the holiday rush, 21st-century style, means doing a majority of your shopping early, and online. Simplify the process even more with these guidelines. mark for My Articles similar articles
The Motley Fool
November 22, 2005
Stephen D. Simpson
Diving Into The Dow: The Fifth Five The authors banter about the relative merits and investment opportunities of some the biggest companies in America: McDonald's... Merck... Microsoft... Pfizer... Procter & Gamble... mark for My Articles similar articles
The Motley Fool
January 12, 2012
Brian Orelli
What to Look For From Pfizer in 2012 Leaner? Yes. Meaner? We'll see. mark for My Articles similar articles
The Motley Fool
September 16, 2010
Matt Koppenheffer
How Much Is McDonald's Worth? Is McDonald's stock on sale? mark for My Articles similar articles
The Motley Fool
December 12, 2008
Rich Smith
This Just In: Upgrades and Downgrades Soleil Securities hands out "buy" ratings to Sepracor, Cephalon, Endo Pharm, and Pfizer. mark for My Articles similar articles
The Motley Fool
October 23, 2009
Rich Smith
This Just In: Upgrades and Downgrades Soleil Securities initiates coverage of three oil stocks. Here is an analysis of their recommendations. mark for My Articles similar articles
The Motley Fool
December 21, 2004
Seth Jayson
Buy Drug Fears? When headlines get bad, both value hunters and rule breakers should start feeling good about buying stock. mark for My Articles similar articles
The Motley Fool
December 18, 2008
Brian Orelli
Best Stock for 2009: Pfizer Pfizer's languishing stock price has made the company so much more attractive; it could see a breakout in 2009. mark for My Articles similar articles
The Motley Fool
February 22, 2007
Brian Lawler
Dueling Fools: Pfizer Bear Rebuttal Generic competition for Lipitor is just the beginning. Faith is nice in terms of religion, but when it comes to investments, investors need to be able to make some reasonable assumptions about future growth plans. mark for My Articles similar articles
The Motley Fool
January 14, 2008
Brian Lawler
Worst Stock for 2008: Pfizer This analyst thinks that Pfizer is a good company, but a bad stock for 2008. mark for My Articles similar articles
The Motley Fool
September 7, 2010
Morgan Housel
Chill Out About Stocks' "Lost Decade" Complaints about stocks' returns are 10 years too late. mark for My Articles similar articles
The Motley Fool
November 16, 2011
Navneet Bajaj
Revealed: The Secret of McDonald's Rich Heritage McDonald's is providing happiness to the foodies and investors. mark for My Articles similar articles